Underreporting of Major Cardiac Adverse Events With Immune Checkpoint Inhibitors in Clinical Trials: Importance of Postmarketing Pharmacovigilance Surveys.
Pascale PalassinJean-Luc FaillieCyrille CoustalXavier QuantinDelphine TopartFrancois RoubilleAlexandre Thibault Jacques MariaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)